Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2012
07/03/2012US8212010 Sphingosine 1-phosphate antagonism
07/03/2012US8212003 Bifunctional fusion protein with thrombolytic and anticoagulant activities and uses thereof
07/03/2012US8211868 Paramyxovirus vector encoding angiogenesis gene and use thereof
07/03/2012US8211867 Targeting microRNAs for the treatment of liver cancer
07/03/2012US8211864 Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
07/03/2012US8211698 Methods of derivation of neuronal progenitor cells from embryonic stem cells
07/03/2012US8211697 Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor
07/03/2012US8211696 Method useful for HCV RNA898 infection
07/03/2012US8211691 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides
07/03/2012US8211690 Modelling in yeast of the mitochondrial ATP6 gene mutations responsible for NARP syndrome in humans and uses thereof for screening for medicaments
07/03/2012US8211685 I-DmoI derivatives with enhanced activity at 37° C and use thereof
07/03/2012US8211683 Plasmid, transformants and process for production of 3- carboxymuconolactone
07/03/2012US8211676 Cholesterol-producing yeast strains and uses thereof
07/03/2012US8211671 Activatable recombinant neurotoxins
07/03/2012US8211670 Production and purification of IL-29
07/03/2012US8211669 mTOR ligands and polynucleotides encoding mTOR ligands
07/03/2012US8211667 Fungal promoter for expressing a gene in a fungal cell
07/03/2012US8211666 Sperm-specific cation channel, CATSPER1, and uses therefor
07/03/2012US8211655 Wild-type receptor assays
07/03/2012US8211648 Secretion of antibodies without signal peptides from bacteria
07/03/2012US8211640 Identification of a family of secreted proteins in vascular endothelium
07/03/2012US8211636 Using electrospray ionization, atmospheric pressure and/or matrix-assisted laser desorption ionization to determine three dimensional structure of nucleic acids
07/03/2012US8211635 P53 modulator and cancer target
07/03/2012US8211631 In vitro model of spinal muscular atrophy
07/03/2012US8211447 Recombinant P. falciparum merozoite protein-142 vaccine
07/03/2012US8211439 Albumin fusion proteins comprising insulin polypeptides
07/03/2012US8211426 ACE2 activation for treatment of heart, lung and kidney disease and hypertension
07/03/2012US8211422 Comprising a first gene segment encoding a single-chain Fv domain (scFv) of a specific antibody and a second gene segment encoding partially or entirely the transmembrane and cytoplasmic domains; gene therapy; antitumor agents
07/03/2012US8211421 Mutant having uracil phosphoribosyl transferase activity
07/03/2012US8211301 Structure and method for handling magnetic particles in biological assays
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2580300C A fast method of transforming competent cells
07/03/2012CA2563264C Connexin 40 tissue specific gene mutations
07/03/2012CA2523328C Isolated bacillus 029 cel cellulase
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2514918C Method to confer cell culture replication activity to different hepatitis c virus isolates
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2463631C Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2446968C Human artificial chromosome containing human antibody .lambda. light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2441595C Proteins producing an altered immunogenic response and methods of making and using the same
07/03/2012CA2407244C Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2403001C Modulating production of pneumococcal capsular polysaccharide
07/03/2012CA2402593C Monoclonal antibodies to the human ldl receptor, their production and use
07/03/2012CA2397610C In vivo assay for testing the phenotypic stability
07/03/2012CA2373385C Method for sequencing nucleic acid molecules
07/03/2012CA2350227C Novel serine protease bssp5
07/03/2012CA2336227C Genes involved in tolerance to environmental stress
07/03/2012CA2330618C Viral chimeras comprised of caev and hiv-1 genetic elements
07/03/2012CA2327387C Cytotoxin-based biological containment
07/03/2012CA2315294C Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
07/03/2012CA2312474C Novel dna cloning method
07/03/2012CA2305269C Treatment of neoplasms with viruses
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2296711C Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
07/03/2012CA2196555C Vr-2332 viral nucleotide sequence and methods of use
06/2012
06/28/2012WO2012088461A2 Linker peptides and polypeptides comprising same
06/28/2012WO2012088434A2 Compositions relating to a phosphoprotein and methods of use
06/28/2012WO2012088428A1 Modified influenza hemagglutinin proteins and uses thereof
06/28/2012WO2012088381A2 Continuous directed evolution
06/28/2012WO2012088342A1 Plant gene expression modulatory sequences from maize
06/28/2012WO2012088290A2 Tri-variable domain binding proteins and uses thereof
06/28/2012WO2012088254A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012WO2012088227A1 Viral promoter, truncations thereof, and methods of use
06/28/2012WO2012088146A2 Biomarkers and uses thereof in prognosis and treatment strategies for right-side colon cancer disease and left-side colon cancer disease
06/28/2012WO2012088071A2 Designer calvin-cycle-channeled and hydrogenotrophic production of butanol and related higher alcohols
06/28/2012WO2012088041A1 Adenoviral vector-based dengue fever vaccine
06/28/2012WO2012088006A1 Fibronectin based scaffold domain proteins that bind il-23
06/28/2012WO2012088001A2 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus
06/28/2012WO2012087983A1 Polycomb-associated non-coding rnas
06/28/2012WO2012087966A2 Targeted perhydrolases
06/28/2012WO2012087964A1 Gene disruptants producing fatty acyl-coa derivatives
06/28/2012WO2012087958A2 Yeast promoters
06/28/2012WO2012087940A1 Viral promoter, truncations thereof, and methods of use
06/28/2012WO2012087889A2 Dna methylation inhibitors
06/28/2012WO2012087835A2 Compositions and methods for enhancing protein folding
06/28/2012WO2012087769A2 A novel cell-based assay to identify polymerase inhibitors for viral infectious disease
06/28/2012WO2012087673A1 Prokaryotic acyl-acp thioesterases for producing fatty acids in genetically engineered microorganisms
06/28/2012WO2012087336A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012WO2012087246A1 Modified human cmv promoters that are resistant to gene silencing
06/28/2012WO2012087242A1 Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138
06/28/2012WO2012087231A1 Affinity chromatography matrix
06/28/2012WO2012087230A1 Affinity chromatography matrix
06/28/2012WO2012087039A2 Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same
06/28/2012WO2012087038A2 Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same
06/28/2012WO2012087017A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
06/28/2012WO2012086909A2 Method for preparing gamma-aminobutyric acids from monosodium glutamate using lactobacillus strains or recombinant lactobacillus strains
06/28/2012WO2012086809A1 Accurate and highly sensitive method for measuring activity of human fgf19 and agent for regulating activity of human fgf19
06/28/2012WO2012086772A1 Analytical device and analytical method
06/28/2012WO2012086756A1 Bioassay method for detecting physiologically active substance
06/28/2012WO2012086702A1 Method for gene introduction
06/28/2012WO2012086660A1 Support for affinity chromatography and method for isolating immunoglobulin
06/28/2012WO2012086647A1 Fusion protein
06/28/2012WO2012086599A1 Detection tool, and detection system
06/28/2012WO2012086450A1 Reaction device for nucleic acid analysis, and nucleic acid analyzer
06/28/2012WO2012086428A1 Medicinal composition comprising calmodulin-like skin protein as active ingredient
06/28/2012WO2012086243A1 Device and method for processing target component in tube
06/28/2012WO2012085911A1 Membrane bound reporter molecules and their use in cell sorting
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 4023